348 related articles for article (PubMed ID: 10353750)
1. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
[TBL] [Abstract][Full Text] [Related]
2. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
Lu X; Xu T; Qian J
Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
[TBL] [Abstract][Full Text] [Related]
3. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.
Lu X; Xu T; Qian J; Wen X; Wu D
Chin Med J (Engl); 2002 Nov; 115(11):1632-6. PubMed ID: 12609076
[TBL] [Abstract][Full Text] [Related]
4. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
Löhr M; Müller P; Mora J; Brinkmann B; Ostwald C; Farré A; Lluis F; Adam U; Stubbe J; Plath F; Nizze H; Hopt UT; Barten M; Capellá G; Liebe S
Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
[TBL] [Abstract][Full Text] [Related]
9. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
10. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
Sawabu N; Watanabe H; Yamaguchi Y; Okai T
Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
[TBL] [Abstract][Full Text] [Related]
12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
13. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
[TBL] [Abstract][Full Text] [Related]
14. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
Behn M; Qun S; Pankow W; Havemann K; Schuermann M
Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
[TBL] [Abstract][Full Text] [Related]
15. Genetic diagnosis of pancreatic cancer.
Mizumoto K; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(1):39-44. PubMed ID: 12021896
[TBL] [Abstract][Full Text] [Related]
16. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region.
Sturm PD; Hruban RH; Ramsoekh TB; Noorduyn LA; Tytgat GN; Gouma DJ; Offerhaus GJ
J Pathol; 1998 Nov; 186(3):247-53. PubMed ID: 10211112
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations.
Gansauge S; Schmid RM; Muller J; Adler G; Mattfeldt T; Beger HG
Br J Surg; 1998 Mar; 85(3):337-40. PubMed ID: 9529487
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
[TBL] [Abstract][Full Text] [Related]
19. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
20. [Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].
Dai MH; Zhao YP; Cai LX; Zhu Y
Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):332-5. PubMed ID: 12892584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
